Rob Vries on organoids for drug discovery and the study of COVID-19

Talking Techniques

English - August 10, 2020 15:26 - 27 minutes - 23.4 MB
Education Science life science biotechniques biotechnology Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Donald Ingber: How COVID-19 is changing conservatism in life sciences

Next Episode: UV LEDs for disinfection and potential protection from SARS-CoV-2

BioTechniques Digital Editor, Tristan Free, speaks to Rob Vries, CEO of Hubrecht Organoid Technology otherwise known as the HUB. We explore the HUB's use of organoids for drug development and further study and improve the clinical treatments of diseases such as cystic fibrosis. After an analysis of the advantages of organoids over 2D cell cultures and animal models, we dive into how HUB's organoids are being used to investigate COVID-19

The Talking Techniques podcast is hosted and produced by Tristan Free for BioTechniques. We would love to here more from our listeners about your opinions on the podcast, what you would like to hear more of and what you think we could do better!

Please get in contact on any of the platforms below.

Twitter: @TristanFreefsg

Email: [email protected]

Hosted on Acast. See acast.com/privacy for more information.